Genetic Association Between Polymorphisms in the ADAMTS14 Gene and Multiple Sclerosis
Overview
Affiliations
ADAMTS14 is a novel member of the ADAMTS (a disintegrin-like and metalloproteinase domain with thrombospondin type 1 modules) metalloproteinase family which processes extracellular matrix proteins. In the present study we performed a comprehensive investigation of the ADAMTS14 as a candidate gene for susceptibility to multiple sclerosis (MS). Eight single nucleotide polymorphisms (SNPs) were analyzed in a case-control study of 287 patients with MS [192 with relapsing-remitting MS (RRMS) and 95 with primary-progressive MS (PPMS)], and 285 age- and sex-matched controls. Allele and genotype frequencies were compared between controls and the MS subgroups, and gene-based haplotypes were reconstructed by computational procedures. Pairwise linkage disequilibrium values (D') suggested that three locus pairs (SNPs 3 through 5) had alleles in strong disequilibrium and constituted a haplotype block spanning 14 kb. Overall comparisons of allele and genotype frequencies showed association for SNPs 3 and 6 with MS. Stratification of MS patients according to major clinical forms revealed an increased frequency of both allele C (p = 0.006) and CC homozygosity (p = 0.008) at SNP6 in RRMS patients compared with controls. PPMS was associated with allele A at SNP2 compared with RRMS (p = 0.003) and controls (p = 0.009), and with CG heterozygosity at SNP3 compared with controls (p = 0.005). Haplotype frequency comparisons showed significant association between PPMS and the AGGGC haplotype compared with controls (p = 0.0004), and negative association between RRMS and the GGAGT haplotype compared with controls (p = 0.0026). No association was detected between different genotypes and disease severity measured by the Multiple Sclerosis Severity Score (MSSS). These findings suggest a potentially important role for the ADAMTS14 gene in predisposition to MS.
The Mechanism and Role of ADAMTS Protein Family in Osteoarthritis.
Li T, Peng J, Li Q, Shu Y, Zhu P, Hao L Biomolecules. 2022; 12(7).
PMID: 35883515 PMC: 9313267. DOI: 10.3390/biom12070959.
Yang H, Khalil R Adv Pharmacol. 2022; 94:255-363.
PMID: 35659374 PMC: 9231755. DOI: 10.1016/bs.apha.2021.11.002.
Lin Y, Lin C, Lu J, Yeh K, Lin S, Yang S Diagnostics (Basel). 2020; 10(2).
PMID: 32102222 PMC: 7168220. DOI: 10.3390/diagnostics10020122.
Zhong S, Khalil R Biochem Pharmacol. 2019; 164:188-204.
PMID: 30905657 PMC: 6580420. DOI: 10.1016/j.bcp.2019.03.033.
ADAMTS14 Gene Polymorphism and Environmental Risk in the Development of Oral Cancer.
Su S, Hsieh M, Liu Y, Chou Y, Lin C, Yang S PLoS One. 2016; 11(7):e0159585.
PMID: 27463966 PMC: 4962993. DOI: 10.1371/journal.pone.0159585.